Eli Lilly Revenue 2010-2025 | LLY

Eli Lilly revenue for the twelve months ending March 31, 2025 was $49.003B, a 36.38% increase year-over-year.

  • Eli Lilly annual revenue for 2024 was $45.043B, a 32% increase from 2023.
  • Eli Lilly annual revenue for 2023 was $34.124B, a 19.56% increase from 2022.
  • Eli Lilly annual revenue for 2022 was $28.541B, a 0.79% increase from 2021.

Eli Lilly Revenue 2010-2025 | LLY

  • Eli Lilly annual revenue for 2024 was $45.043B, a 32% increase from 2023.
  • Eli Lilly annual revenue for 2023 was $34.124B, a 19.56% increase from 2022.
  • Eli Lilly annual revenue for 2022 was $28.541B, a 0.79% increase from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B